Evaluate the safety and tolerability of OBM's ocular gene therapy products in targeted populations.
Conducting clinical studies for persons with inherited orphan retinal degenerative diseases and dry age-related macular degeneration (AMD).
Ophthalmic Training and Certification facilitates standardization in data collection which improves the integrity of the overall study outcome.
SCORE2 is designed to assess whether bevacizumab is non-inferior to aflibercept for the treatment of macular edema associated with CRVO.
Phase III trial compared efficacy and safety of standard care vs. triamcinolone injection(s) for macular edema associated with retinal vein occlusion.
NEIS provides a full range of data management, statistical and information support for clinical research sponsored by the National Eye Institute.
The goal of AREDS2 is to assess the effects of supplemental doses of lutein, zeaxanthin, DHA and EPA on the progression to advanced AMD and cataract.
The goal of the Age-Related Eye Disease Study is to learn about macular degeneration and cataract, two leading causes of vision loss in older adults.
The purpose of The MacTel Project is to identify the causes and appropriate treatments for Idiopathic Juxtafoveal Macular Telangiectasia.